Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Morrow, Georgia 30260


Purpose:

This study will evaluate the safety, efficacy, tolerability, and systemic pharmacokinetics of 3 different doses of topical ophthalmic AGN-223575 suspension compared to AGN-223575 vehicle in patients with dry eye disease.


Criteria:

Inclusion Criteria: - Signs and symptoms of dry eye disease - Has used RESTASIS and/or artificial tears in both eyes twice a day for at least 60 days. Exclusion Criteria: - History of glaucoma, or ocular hypertension - Diagnosis of ocular infection - Use of contact lenses in the past 14 days or expected use during the study - Use of any topical ophthalmic medications in the past 30 days - Use of corticosteroids in the past 30 days.


NCT ID:

NCT02435914


Primary Contact:

Study Director
Medical Director
Allergan


Backup Contact:

N/A


Location Contact:

Morrow, Georgia 30260
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.